| Literature DB >> 30256006 |
Dušica Simić-Panić1, Ksenija Bošković1, Marija Milićević2, Tamara Rabi Žikić3, Mina Cvjetković Bošnjak4, Snežana Tomašević-Todorović1, Mirjana Jovićević3.
Abstract
Comorbidity decreases survival but it still remains unknown to what extent functional recovery after ischemic stroke is affected. The aim of this research was to determine the prevalence of the most common comorbidities in patients with ischemic stroke and to examine their predictive value on the functional status and recovery. In order to obtain relevant information for this research, we conducted a prospective study over a two-year period. It included patients with acute/subacute ischemic stroke who had inhospital rehabilitation treatment in our institution. Functional status of the patients was evaluated by the following three aspects at the beginning and at the end of rehabilitation treatment: Rivermead Mobility Index was used for mobility, Barthel Index for independence in activities of daily living, and modified Rankin Scale for total disability. Modified Charlston Comorbidity Index was used to assess comorbidity. Multivariate analysis was applied to evaluate the impact of recorded comorbidities on the patient functional outcome. Independent predictors of rehabilitation success in our study were the value of modified Charlston Comorbidity Index, atrial fibrillation and myocardial infarction. Our study demonstrated that patients with more comorbidities had worse functional outcome after stroke, so it is important to consider the comorbidity status when planning the rehabilitation treatment.Entities:
Keywords: Comorbidity; Recovery of function; Rehabilitation; Stroke; Stroke – rehabilitation; Treatment outcome
Mesh:
Year: 2018 PMID: 30256006 PMCID: PMC6400340 DOI: 10.20471/acc.2018.57.01.01
Source DB: PubMed Journal: Acta Clin Croat ISSN: 0353-9466 Impact factor: 0.780
Fig. 1Flow diagram showing study phases and patients analyzed and excluded from the study.
Demographic and clinical characteristics of patients
| Admission | Discharge | *p-value | |
|---|---|---|---|
| Subjects, N | 403 | ||
| Age (yrs) | 63.9±40.5 | ||
| Range | 20-90 | ||
| Sex | 230 (57.1) | ||
| Type of disability | 159 (39.2) | ||
| NIHSS | 10.3±4.45 | 7.01±3.76 | <0.001 |
NIHSS = National Institute of Health Stroke Scale; BMES = Brunnstrom Motor Evaluation Scale; BI = Barthel Index; RMI = Rivermead Mobility Index; mRS = Modified Rankin Scale; *p calculated using Student’s t-test for comparisons of continuous variables and Wilcoxon signed rank test for comparisons of differences between pre- and post measures of Brunnstrom Motor Evaluation
Rehabilitation outcome in relation to comorbidities and modified CCI values
| Rehabilitation outcome | Unsuccessful | Successful | Total | *p |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | ||
| Hypertension | ||||
| Yes | 220 (66.3) | 112 (33.7) | 332 (100.0) | < 0.001 |
| No | 22 (31.0) | 49 (69.0) | 71 (100.0) | |
| Atrial fibrillation | ||||
| Yes | 57 (91.9) | 5 (8.1) | 62 (100.0) | <0.001 |
| No | 185 (54.3) | 156 (45.7) | 341 (100.0) | |
| Myocardial infarction | ||||
| Yes | 60 (87.0) | 9 (13.0) | 69 (100.0) | <0.001 |
| No | 182 (54.5) | 152 (45.5) | 334 (100.0) | |
| Dilatative cardiomyopathy | ||||
| Yes | 40 (100.0) | 0 (0.0) | 40 (100.0) | <0.001 |
| No | 202 (55.6) | 161 (44.4) | 361 (100.0) | |
| Diabetes mellitus | ||||
| Yes | 98 (71.5) | 39 (28.5) | 137 (100.0) | =0.001 |
| No | 144 (54.1) | 122 (45.9) | 266 (100.0) | |
| Modified CCI | ||||
| n (%) | 242 (60.0) | 161 (40.0) | 403 (100.0) | |
| Mean value±SD | 4.17±1.49 | 2.16±1.14 | 3.24±1.56 | <0.001** |
| Median (range) | 5 (0 – 8) | 2 (0 – 5) | ||
| Modified CCI <3 | ||||
| n (%) | 11 (19.3) | 46 (80.7) | 57 (100.0) | |
| Modified CCI ≥3 | <0.001 | |||
| n (%) | 231 (66.8) | 115 (33.2) | 346 (100.0) |
CCI = Charlston Comorbidity Index; *p calculated using Student’s t-test for comparisons of continuous variables; **p calculated using Mann Whitney U test
Univariate and multivariate linear regression analysis (ENTER method)
| Determinant | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| p | Beta | p | Beta | |
| Modified CCI | 0.000 | -0.584 | 0.000 | -0.408 |
| Hypertension | 0.012 | -0.175 | 0.058 | -0.023 |
| Atrial fibrillation | 0.000 | -0.479 | 0.006 | -0.061 |
| Myocardial infarction | 0.001 | -0.357 | 0.029 | -0.454 |
| Dilated cardiomyopathy | 0.004 | -0.289 | 0.998 | -0.010 |
| Diabetes mellitus | 0.001 | 0.178 | 0.547 | 0.023 |
CCI = Charlston Comorbidity Index